The Medicines Company Provides Progress Update on Ongoing ORION-1 Study of PCSK9si

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to The Medicines Company Provides Progress Update on Ongoing ORION-1 Study of PCSK9si

Jefferies Sees No Read-Through to The Medicines Company (MDCO) PCSK9 from Alnylam Setback

October 6, 2016 6:44 AM EDT

Jefferies analyst Biren Amin reiterated his Buy rating and $43 price target on The Medicines Company (NASDAQ: MDCO) saying Alnylam Pharmaceuticals (NASDAQ: ALNY) set back has no read-through to the company's PCSK9 Program.

Amin commented, "ALNY... More

Medicines Co. (MDCO) Sells-Off with Alnylam (ALNY) Despite Providing Update

October 5, 2016 5:54 PM EDT

Medicines Co. (NASDAQ: MDCO) is down 9.1% after-hours after Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced that upon the recommendation of the ENDEAVOUR Phase 3 study Data Monitoring Committee (DMC) to suspend dosing, the Company has decided to discontinue development of revusiran, an... More